Associated Banc-Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Associated Banc-Corp’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-166	Closed	-$1K	–	1039
2020 Q3	$1K	Buy	+166	New	+$993	﹤0.01%	966

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Associated Banc-Corp's CLVS Position: Q4 2020 in Review

Associated Banc-Corp sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 166 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in CLVS in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

Associated Banc-Corp reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
Associated Banc-Corp sold 166 Clovis Oncology, Inc. shares in Q4 2020, an estimated $1K.
Associated Banc-Corp first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 1 quarter.
Associated Banc-Corp's Clovis Oncology, Inc. position peaked at $1K in Q3 2020.
159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Associated Banc-Corp's 13F filing for Q4 2020, filed 11 Feb 2021.